Interview with Johan Sandin (CSO) in Aktiespararna’s analysis guide
AlzeCure Pharma provides a scientific update on Alzheimer’s disease and the Alzstatin project platform
Presentation with Redeye – Science & Market update – September 1, 2020
Welcome to AlzeCure…
CEO presentation video – Annual meeting May 20 2020 (Swedish)
Lär känna vd Martin Jönsson – Redeye Research Interview March 19, 2020 (Swedish)
Aktiedagen March 16, 2020 (Swedish)
About Alzstatin
About Alzheimers disease
About NeuroRestore
